A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia. The researchers compared the health outcomes of more than 110,000 people aged 40–69 with type 2 diabetes who had been prescribed a type of drug called SGLT-2 inhibitors with those of another 110,000 patients taking a different class of drug, DPP-4 inhibitors. They followed participants for an average of 670 days. The researchers found that, after accounting for potential confounding factors, those taking an SGLT-2 inhibitor wer…
